argenx SE American Depositary Shares

Notable Price Movement

1. Aug 3-7$844.501.09%

   argenx fell $27.73, or 3.18%, from $872.23 on July 28 to $844.50 on August 4. The stock initially rose 1.18% on July 29, then reversed, slipping 1.13% on July 30 and 2.15% on July 31 before giving back the full early gain with a further 2.70% decline on August 3. It recovered 1.65% on August 4 but remained below the prior close. The supplied evidence identifies no company-specific announcement driving the move. Instead, broader biotechnology positioning may have weighed on sentiment: BNK Invest reported approximately $141.5 million of weekly outflows from the iShares Biotechnology ETF, a 1.5% decline in shares outstanding. Zacks’ Buy upgrade provided a positive counterpoint.

   12 sources

Stories & Analysis

What Makes Argenx (ARGX) a New Buy StockZacks · 1d agoFTRE vs. ARGX: Which Stock Is the Better Value Option?Zacks · 5d agoIBB, REGN, ARGX, ALNY: Large Outflows Detected at ETFBNK Invest · 6d agoargenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102MarketBeat · Jul 27Argenx To Acquire Forte For Approx. $2.2 Bln To Expand Immunology Pipeline; Forte Shares SoarRTTNews · Jul 27October 16th Options Now Available For argenx (ARGX)BNK Invest · Jul 24argenex Q2 Earnings Call HighlightsMarketBeat · Jul 23Argenx Q2 Sales Jump 60%; Expects Multiple Readouts Ahead For VYVGART And Empasiprubart; Stock UpRTTNews · Jul 23